Pay in 4 interest-free payments of $6.22 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Retarutide (LY3437943) is a triple agonist peptide of glucagon receptor (GCGR), glucose-dependent insulin-promoting peptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R)
Of those that currently offer GLP-1 drug coverage only for diabetes, 20% are considering offering the drugs for weight loss (up from 9% in 2024)
These drugs help control blood sugar and may lead to weight loss
A welcome deal is only as good as its clarity: wagering targets, game weighting, contribution caps, and expiry windows should be written in plain language, not buried in footnotes
Takes a while for you start losing weight.* Was this helpful
US$ 23.41
US$ 27.19
US$ 28.24
US$ 25.98
US$ 21.37
